EP 0895475 A4 20000823 - VITRONECTIN RECEPTOR ANTAGONISTS
Title (en)
VITRONECTIN RECEPTOR ANTAGONISTS
Title (de)
VITRONECTIN REZEPTOR ANTAGONISTEN
Title (fr)
ANTAGONISTES DU RECEPTEUR DE VITRONECTINE
Publication
Application
Priority
- US 9620744 W 19961220
- US 953295 P 19951229
Abstract (en)
[origin: WO9724122A1] Compounds of formula (I) are disclosed which are vitronectin receptor antagonists useful in the treatment of osteoporosis.
IPC 1-7
C07D 401/12; C07D 403/12; C07D 487/04; C07D 213/73; C07D 401/06; C07D 413/06; C07D 401/10; C07D 405/12
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/44 (2006.01); A61K 31/4427 (2006.01); A61K 31/443 (2006.01); A61K 31/4439 (2006.01); A61K 31/445 (2006.01); A61K 31/4465 (2006.01); A61K 31/4523 (2006.01); A61K 31/4545 (2006.01); A61K 31/47 (2006.01); A61K 31/472 (2006.01); A61K 31/4725 (2006.01); A61K 31/495 (2006.01); A61K 31/4965 (2006.01); A61K 31/497 (2006.01); A61K 31/50 (2006.01); A61K 31/501 (2006.01); A61K 31/55 (2006.01); A61K 31/551 (2006.01); A61K 31/5513 (2006.01); A61K 31/5517 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 19/00 (2006.01); A61P 19/10 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 213/73 (2006.01); C07D 401/04 (2006.01); C07D 401/06 (2006.01); C07D 401/10 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01); C07D 413/06 (2006.01); C07D 487/04 (2006.01)
CPC (source: EP KR)
A61K 31/44 (2013.01 - KR); A61P 9/00 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 19/00 (2018.01 - EP); A61P 19/10 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 213/73 (2013.01 - EP); C07D 401/02 (2013.01 - KR); C07D 401/04 (2013.01 - EP); C07D 401/06 (2013.01 - EP); C07D 401/10 (2013.01 - EP); C07D 401/12 (2013.01 - EP); C07D 405/12 (2013.01 - EP); C07D 413/06 (2013.01 - EP); C07D 487/04 (2013.01 - EP)
Citation (search report)
- [XD] WO 9300095 A2 19930107 - SMITHKLINE BEECHAM CORP [US]
- [XD] WO 9414776 A2 19940707 - SMITHKLINE BEECHAM CORP [US], et al
- [PXD] WO 9600574 A1 19960111 - SMITHKLINE BEECHAM CORP [US], et al
- [E] WO 9724124 A1 19970710 - SMITHKLINE BEECHAM CORP [US], et al
- [E] WO 9724336 A2 19970710 - SMITHKLINE BEECHAM PLC [GB], et al
- [A] BONDINELL W E ET AL: "DESIGN OF A POTENT AND ORALLY ACTIVE NONPEPTIDE PLATELET FIBRINOGEN RECEPTOR (GPIIB/IIIA) ANTAGONIST", BIOORGANIC & MEDICINAL CHEMISTRY, GB, ELSEVIER SCIENCE LTD, vol. 2, no. 9, May 1994 (1994-05-01), pages 897 - 908, XP000196285, ISSN: 0968-0896
- See also references of WO 9724122A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9724122 A1 19970710; AU 1353897 A 19970728; BR 9612378 A 19990713; CA 2241724 A1 19970710; CN 1209060 A 19990224; CZ 203798 A3 19981216; EP 0895475 A1 19990210; EP 0895475 A4 20000823; HU P9901116 A2 20000328; IL 125034 A0 19990126; JP 2000502708 A 20000307; KR 19990076876 A 19991025; MX 9805253 A 19981031; NO 983002 D0 19980626; NO 983002 L 19980826; PL 327919 A1 19990104; TR 199801255 T2 19981021; ZA 9610855 B 19971124
DOCDB simple family (application)
US 9620744 W 19961220; AU 1353897 A 19961220; BR 9612378 A 19961220; CA 2241724 A 19961220; CN 96180099 A 19961220; CZ 203798 A 19961220; EP 96945085 A 19961220; HU P9901116 A 19961220; IL 12503496 A 19961220; JP 52455697 A 19961220; KR 19980705003 A 19980627; MX 9805253 A 19980626; NO 983002 A 19980626; PL 32791996 A 19961220; TR 9801255 T 19961220; ZA 9610855 A 19961223